Measles, mumps, and rubella vaccination: timing and restrictions

The measles, mumps, and rubella vaccine is a live, attenuated combination vaccine designed for active immunoprophylaxis of three highly contagious infections that can cause severe complications in children and adults. Modern vaccine series demonstrate high efficacy and a favorable safety profile, and a two-dose regimen provides consistent protection against measles in the vast majority of those vaccinated. [1]

In 2024-2025, a new surge in measles cases is expected in Europe and several countries, amidst immune "gaps" and declining routine immunization coverage. This increases the need for timely vaccination, vaccination status verification, and catch-up vaccinations, especially before travel and group education. [2]

Measles remains one of the most contagious respiratory infections, transmitted by aerosols and airborne droplets, making vaccination a key measure for individual and population protection. A combination vaccine simultaneously covers the risks of three diseases, reducing the number of visits and injections, which increases compliance. [3]

There's no need to overestimate common "myths" about supposedly frequent severe reactions or a link between vaccines and autism spectrum disorders: large studies and meta-analyses have convincingly demonstrated the absence of an association between vaccination and autism. This is an important point for frank dialogue with families who are hesitant about vaccinations. [4]

What exactly is a vaccine?

Commercial preparations used in Europe include variants based on the Schwartz measles, RIT 4385 mumps, and RA 27/3 rubella strains. They are produced in lyophilized form with a separate solvent and are administered subcutaneously after reconstitution. The composition and production technology comply with international requirements for live combination vaccines. [5]

Once reconstituted, the prepared solution should be used immediately or stored for a limited time in the refrigerator at 2 to 8°C, as per the instructions. For European products, short-term refrigeration for up to 8 hours is permitted; freezing is not permitted. Store in the cardboard packaging to protect from light. [6]

Differences between brands relate to release forms and storage details, but the principle of action is the same: each component generates a specific immune response. In practice, the drugs are interchangeable, provided the minimum intervals between doses and storage regulations are observed. [7]

Table 1. Drugs and key parameters

Preparation	Age of indications	Type	Storage before dilution	After breeding
MM-RvaxPro	from 12 months	live combined	2-8 °C, do not freeze, protect from light	use immediately or within 8 hours at 2-8 °C
Priorix	from 9-12 months depending on the country	live combined	2-8 °C, light protection	preferably immediately, up to 8 hours at 2-8 °C is acceptable

Source: White papers on products and regulatory materials. [8]

Efficiency and benefits

One dose of the combination vaccine protects against measles by approximately 93%, while two doses provide approximately 97% protection. This represents a significant reduction in the risk of infection and virus circulation with sufficient population coverage. Efficacy against mumps is somewhat lower and may decline over time, which explains outbreaks in crowded settings when immune systems are fatigued. [9]

Two-dose rubella vaccination provides high levels of seroprotection and is a critical barrier against congenital rubella, which is dangerous to the fetus. Maintaining herd immunity prevents vertical transmission and outbreaks. [10]

Studies on "fading" protection show that immunity against mumps can wane over decades, so in some outbreaks, supplemental doses are considered for high-risk groups based on epidemiological indications. This does not change the basic regimen for most people, but is important for outbreaks. [11]

With the incidence of measles rising in Europe, vaccination remains the most effective preventative measure, and timely administration of the second dose significantly reduces the risk of severe complications and hospitalisations. [12]

Table 2. Performance indicators

Infection	Efficiency of 1 dose	Efficiency of 2 doses	Comment
Measles	≈93%	≈97%	high protection and pronounced population effect
Epidemic mumps	49-82%	66-88%	possible decline over time in individual cohorts
Rubella	high	high	the key to preventing congenital rubella

Sources: CDC, systematic reviews, and cohorts. [13]

Who is eligible for vaccination and when?

The routine regimen for children is the first dose at 12-15 months of age, the second at 4-6 years of age. An earlier second dose may be given, provided a minimum interval of at least 28 days is observed, which is useful before starting kindergarten or school. [14]

It is important for travelers and their families to complete their vaccinations at least two weeks before departure. Infants aged 6 to 11 months traveling abroad are recommended to receive a "zero" dose, which is not included in the routine schedule and requires a full course to be repeated after 12 months. [15]

Adolescents and adults without evidence of immunity should receive one or two doses at least 28 days apart. Healthcare workers, students, and those living in dormitories often require proof of two doses or laboratory immunity. [16]

National vaccination schedules across Europe follow similar principles: two doses for sustained protection, with variations in the age of the second dose. In Spain, for example, the recommended dose is the first dose at 12 months and the second at 2 years of age for the combined measles, mumps, rubella, and chickenpox vaccine, according to the schedule of the professional pediatric society. [17]

Table 3. Summary vaccination schedules by situation

Situation	Scheme
Children according to the calendar	12-15 months and 4-6 years, minimum 28 days between doses if terminated early
Traveling abroad, children 6-11 months	one "zero" dose before the trip, then a full course after 12 months
Teenagers and adults without immunity	2 doses at least 28 days apart
Healthcare workers, students, dormitory accommodation	confirmed 2 doses or laboratory evidence of immunity

Sources: CDC, travel guidelines.[18]

Catch-up vaccination and evidence of immunity

Evidence of immunity includes two documented doses after 12 months of age, laboratory confirmation of immunoglobulin G levels, or laboratory-confirmed past illnesses. In some countries, individuals born before a certain age are considered likely immune to measles and rubella, but this varies and requires consultation with local guidelines. [19]

If documents are missing, it's safer to re-vaccinate using the full catch-up schedule of two doses, spaced as closely as possible. Revaccination in already immune individuals is safe, and searching for old records often delays protection for months. This approach is supported by practical recommendations for outbreaks and organized groups. [20]

For travel and during outbreaks, minimal intervals are actively used to complete the course more quickly and close the immune "windows." If the standard timeframes are not possible, preference is given to at least one dose before departure. [21]

In isolated mumps outbreaks, additional doses are considered for high-risk groups based on epidemiological indications, based on data on fading protection. This decision is made by the health service; this is not a routine tactic for everyone. [22]

Table 4. Minimum intervals and quick scenarios

Situation	Minimum interval
Between doses of combination vaccine	at least 28 days
Early completion of the course before the trip	acceptable if the interval is at least 28 days
"Zero" dose at 6-11 months	does not count, then 2 doses after 12 months

Source: CDC. [23]

Post-exposure prophylaxis of measles

After exposure to a measles patient, vaccination within the first 72 hours can prevent the disease or mitigate its course in susceptible individuals in the absence of contraindications. This is the first line of emergency prevention for most people over 12 months of age. [24]

If more time has passed or the vaccine is contraindicated, intramuscular immunoglobulin should be administered as soon as possible, but no later than 6 days after the onset of exposure. The recommended dose for the intramuscular route is 0.5 ml per kilogram of body weight with a maximum volume of 15 ml. [25]

Pregnant women without immunity and those with severe immunosuppression are prescribed intravenous immunoglobulin at a dose of 400 mg per kilogram. Concomitant administration of the vaccine and immunoglobulin is unacceptable, as this "quench[s]" the response to the live vaccine. [26]

Individuals who have received immunoglobulin should delay vaccination for several months, depending on the dose and route of administration, to avoid compromising the immune response to the live vaccine. Specific intervals are provided in the general principles of immunization for antibody-containing products. [27]

Table 5. Post-exposure prophylaxis for measles

Category	Up to 72 hours	From 4th to 6th day	Notes
Over 12 months, no contraindications	vaccine	immunoglobulin as indicated	do not combine vaccination and immunoglobulin
Infants up to 12 months	depending on the situation, see notes	immunoglobulin 0.5 ml per kg, maximum 15 ml	"zero" dose up to 12 months requires a repeat course after 12 months.
Pregnant women without immunity	do not administer a live vaccine	intravenous immunoglobulin 400 mg/kg	vaccination - after childbirth
Severe immunosuppression	do not administer a live vaccine	intravenous immunoglobulin 400 mg/kg	individually depending on the condition

Sources: CDC, health departments. [28]

Contraindications and precautions

Absolute contraindications include pregnancy, severe primary or secondary immunosuppression, and anaphylaxis to a previous dose or vaccine components, including gelatin and neomycin. The vaccine is not administered to patients with high fever until the condition has stabilized. [29]

An allergy to chicken protein is not a contraindication to the combination vaccine. Post-vaccination reactions are usually related to gelatin or neomycin, not trace amounts of egg protein, as the production process uses chicken embryo cells, not egg protein.[30]

Precautions include recent administration of immunoglobulins and blood products, which requires an interval before live vaccines. Interactions with tuberculosis diagnostics are also considered: skin tests and IGRAs are performed on the same day or delayed for at least 4 weeks after vaccination. [31]

If there is any doubt about contraindications, one should be guided by the current general principles of immunization and consult a specialist, especially in patients with oncohematological diseases, after transplants or on biological therapy. [32]

Table 6. Contraindications and precautions

Paragraph	Status
Pregnancy	contraindication
Severe immunosuppression	contraindication
Anaphylaxis to gelatin, neomycin, or previous dose	contraindication
Egg allergy	is not a contraindication
Recent use of immunoglobulins	interval required before live vaccines
Active high fever	temporary medical exemption

Sources: CDC, national guidelines. [33]

Special groups: pregnancy, postpartum period, immunodeficiencies, allergies

Live vaccines are not administered to pregnant women; however, postpartum vaccination is strongly recommended in the absence of immunity to rubella and measles to protect the woman and future pregnancies. It is recommended to avoid pregnancy for 28 days after vaccination. [34]

In cases of severe immunosuppression, the vaccine is contraindicated. For contacts with measles in such groups, intravenous immunoglobulin is indicated. HIV-infected individuals without severe immunosuppression are considered individually according to specialized recommendations. [35]

Allergic individuals with a history of reactions to gelatin and neomycin require risk assessment, while individuals with chicken protein allergy are routinely vaccinated under conditions of preparedness for the treatment of anaphylaxis. These provisions are supported by international guidelines and practice. [36]

For newborns and infants, the choice of strategy depends on the epidemiological data and contacts. For travel at ages 6 to 11 months, a "zero" dose is used followed by a full course; for contacts, immunoglobulin is administered based on time and weight. [37]

Compatibility with other vaccines and diagnostics

The combination vaccine can be administered on the same day as other inactivated vaccines at different injection sites. When administered concurrently with another live vaccine, it should be administered on the same day or at least 28 days apart. This prevents cross-influence on the immune response. [38]

After the administration of immunoglobulins or blood products, live vaccines are delayed for the recommended period, which depends on the dose and route of administration of the antibody-containing product. These intervals are mandatory for emergency measles prophylaxis with immunoglobulin. [39]

The Mantoux test and gamma interferon release tests may falsely decrease in the weeks following a live vaccine. They are performed on the same day before or at the same time as vaccination, or no earlier than 4 weeks after. [40]

For the first dose at 12-23 months of age, when combined measles, mumps, rubella, and varicella vaccine is given, there is a small additional risk of febrile seizures compared to separate administration. Therefore, many schedulers prefer the separate schedule at the first visit. [41]

Table 7. Intervals and combinations

Situation	Rule
Two live vaccines	on one day or at least at an interval of 28 days
After immunoglobulin	maintain the interval according to the tables of general principles of immunization
Tests for tuberculosis	on the same day or 4 weeks after vaccination
Combination vaccine with chickenpox at 12-23 months.	There may be an increased risk of febrile seizures; separate administration is more often chosen

Sources: CDC, Safety Materials. [42]

Safety: Common and Rare Reactions, Myths and Facts

Common reactions include redness, soreness at the injection site, a short-term increase in temperature, and a rash within 5-12 days. These reactions resolve spontaneously and do not require specific therapy other than symptomatic measures. [43]

Rare reactions include thrombocytopenic purpura and anaphylactic reactions in those sensitized to gelatin or neomycin. Their incidence is extremely low and disproportionate to the risk of complications from the infections themselves that vaccination protects against. [44]

For a combination vaccine that also includes a varicella component, a small increase in the risk of febrile seizures has been reported 7–10 days after the first dose in children 12–23 months of age, which is taken into account in the practical recommendations for choosing separate administration at the first visit. [45]

No link has been found between vaccination and autism spectrum disorders. A large meta-analysis and cohorts involving hundreds of thousands of children have shown no increased risk after vaccination, specifically after the combination vaccine. This is one of the most studied issues in vaccinology. [46]

Table 8. Frequency and nature of adverse events

Reaction	Typical frequency	Deadlines	Comment
Pain, redness	often	on the first day	self-limit
Fever	often	Days 5-12	symptomatic therapy
Rash	Sometimes	Days 5-12	short-term
Febrile seizures with combination vaccine and chickenpox	slight increase in risk	Days 7-10	alternative - separate administration
Anaphylaxis	extremely rare	minutes - hours	associated with gelatin and neomycin

Sources: regulatory documents, CDC. [47]

Practice before and after vaccination

Before vaccination, the patient is assessed for contraindications, epidemiological indications, and documentation of previous doses. No special preparation is required, other than information about typical reactions, observation guidelines, and rare risks. [48]

After vaccination, observation at the facility is recommended for at least 15 minutes; if there is a history of severe allergies, longer observation is recommended at the discretion of the physician. Normal activity and hygiene are permitted; there are no specific restrictions. Antipyretics are used based on symptoms. [49]

When traveling, it's important to plan your vaccinations in advance to ensure you meet the deadlines and, if necessary, receive a second dose before departure. If time is short, at least the first dose is administered, as even partial protection is better than complete lack of immunity. [50]

If a tuberculosis test is scheduled within a few days after vaccination, it is rescheduled or performed on the day of vaccination. For transfusions and immunoglobulins, the schedule is adjusted to accommodate the required intervals. [51]

Table 9. Brief tips for the patient

Situation	What to do
Past vaccine hesitancy	get vaccinated according to the catch-up schedule of 2 doses
Traveling in less than 2 weeks	get the first dose immediately, the second one as late as possible
Egg allergy	This is not an obstacle to vaccination.
Pregnancy	wait until the postpartum period
Contact with measles	emergency vaccination up to 72 hours or immunoglobulin up to 6 days according to indications

Sources: CDC, travel and post-exposure prophylaxis guidelines.[52]

Frequently Asked Questions

Should I get an antibody test instead of a vaccination if I don't have a card?
No. It's easier and more reliable to get a catch-up vaccination. Booster vaccination is safe even if you already have immunity. [53]

Can I get vaccinated if I have an egg allergy?
Yes. An allergy to chicken protein is not a contraindication to this combination vaccine. The risk of anaphylaxis is primarily associated with gelatin and neomycin. [54]

What should pregnant women do if they are not immune to rubella or measles?
Live vaccines are not used during pregnancy. Postpartum, vaccination should be initiated as early as possible and pregnancy should be avoided for 28 days after vaccination. Intravenous immunoglobulin is indicated for those exposed to measles. [55]

Why do some countries recommend separate administration at 12-23 months?
Because a small increased risk of febrile seizures has been reported for the combination vaccine, which includes a component against chickenpox. Separating the vaccine reduces this risk while maintaining efficacy. [56]

Is there evidence linking vaccinations to autism?
Large studies and meta-analyses have shown no such link. This is supported by high-level evidence. [57]

Codes for medical documentation

Vaccination materials often use ICD codes to describe vaccinations and reasons for their administration or refusal, as well as disease codes for epidemiological anamnesis and related reporting. For practical purposes, it is useful to know both sets of codes. [58]

Table 10. Codes according to ICD-10 and ICD-11

Essence	ICD-10	ICD-11
Measles	B05	1E90
Epidemic mumps	B26	1E82
Rubella	B06	1E91
Congenital rubella	P35.0	neonatal conditions, positions in the perinatal codes section
Application for vaccination	Z23	XK8G or corresponding immunization event codes in the electronic record

Sources: official published code lists. [59]

Conclusions

The combined measles, mumps, and rubella vaccine remains one of the most important vaccinations for children and adults. Two doses provide reliable protection against measles, and timely adherence to the schedule and catch-up schedules prevents outbreaks and severe outcomes. There are clear windows for emergency prophylaxis in cases of exposure to measles. Myths about its unsafe nature and link to autism have been refuted by robust evidence. [60]